LifeStance Health Group (LFST) Competitors $5.48 +0.04 (+0.64%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFST vs. GH, OPCH, RDNT, SHC, BTSG, SGRY, WGS, CON, PRVA, and VCYTShould you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. LifeStance Health Group vs. Its Competitors Guardant Health Option Care Health RadNet Sotera Health BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Privia Health Group Veracyte Guardant Health (NASDAQ:GH) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings. Does the media favor GH or LFST? In the previous week, Guardant Health had 8 more articles in the media than LifeStance Health Group. MarketBeat recorded 14 mentions for Guardant Health and 6 mentions for LifeStance Health Group. Guardant Health's average media sentiment score of 1.08 beat LifeStance Health Group's score of 0.83 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeStance Health Group 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GH or LFST more profitable? LifeStance Health Group has a net margin of -1.23% compared to Guardant Health's net margin of -49.93%. Guardant Health's return on equity of 0.00% beat LifeStance Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% LifeStance Health Group -1.23%-1.11%-0.76% Which has more risk & volatility, GH or LFST? Guardant Health has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, LifeStance Health Group has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Which has higher valuation & earnings, GH or LFST? LifeStance Health Group has higher revenue and earnings than Guardant Health. LifeStance Health Group is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M10.04-$436.37M-$3.35-17.77LifeStance Health Group$1.25B1.70-$57.44M-$0.05-109.50 Do insiders & institutionals believe in GH or LFST? 92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Comparatively, 6.6% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend GH or LFST? Guardant Health currently has a consensus price target of $57.50, indicating a potential downside of 3.38%. LifeStance Health Group has a consensus price target of $8.50, indicating a potential upside of 55.25%. Given LifeStance Health Group's higher probable upside, analysts clearly believe LifeStance Health Group is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06LifeStance Health Group 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86 SummaryGuardant Health beats LifeStance Health Group on 9 of the 16 factors compared between the two stocks. Get LifeStance Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFST vs. The Competition Export to ExcelMetricLifeStance Health GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.13B$4.03B$5.71B$9.79BDividend YieldN/A1.26%3.77%4.10%P/E Ratio-109.5026.2330.9125.28Price / Sales1.7021.22404.2188.50Price / Cash137.1926.5625.2228.45Price / Book1.454.469.536.01Net Income-$57.44M$189.47M$3.26B$265.34M7 Day Performance19.80%2.50%4.66%2.89%1 Month Performance29.74%11.68%5.35%1.61%1 Year Performance-3.10%9.91%32.14%25.61% LifeStance Health Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFSTLifeStance Health Group3.2338 of 5 stars$5.48+0.6%$8.50+55.3%-3.7%$2.13B$1.25B-109.5010,218GHGuardant Health3.1751 of 5 stars$54.80+1.1%$57.50+4.9%+110.7%$6.76B$739.02M-16.362,021Positive NewsOPCHOption Care Health4.6565 of 5 stars$27.85-1.2%$35.75+28.4%-9.7%$4.58B$5.00B22.288,088News CoveragePositive NewsRDNTRadNet3.3232 of 5 stars$62.00+16.2%$69.60+12.3%+4.7%$4.00B$1.83B-144.1811,021News CoveragePositive NewsAnalyst UpgradeInsider TradeHigh Trading VolumeSHCSotera Health1.2053 of 5 stars$14.06+0.6%$16.00+13.8%+5.1%$3.97B$1.10B175.773,000Analyst UpgradeHigh Trading VolumeBTSGBrightSpring Health Services2.6394 of 5 stars$20.66-0.6%$25.67+24.2%+86.8%$3.68B$11.27B66.6535,000Positive NewsSGRYSurgery Partners3.1191 of 5 stars$22.74-3.8%$33.00+45.1%-21.4%$3.03B$3.11B-15.9015,000Insider TradeWGSGeneDx1.9559 of 5 stars$110.54+5.1%$101.63-8.1%+265.5%$3.02B$305.45M2,210.801,200CONConcentra Group Holdings Parent2.3123 of 5 stars$21.47-0.7%$28.50+32.7%-0.9%$2.77B$1.90B18.0411,250PRVAPrivia Health Group3.4645 of 5 stars$20.31-1.3%$28.00+37.9%+6.9%$2.53B$1.74B184.651,140VCYTVeracyte2.9259 of 5 stars$27.99+2.3%$40.90+46.1%-8.0%$2.15B$445.76M84.82790News Coverage Related Companies and Tools Related Companies GH Competitors OPCH Competitors RDNT Competitors SHC Competitors BTSG Competitors SGRY Competitors WGS Competitors CON Competitors PRVA Competitors VCYT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFST) was last updated on 8/18/2025 by MarketBeat.com Staff From Our Partners"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access